SGLT2 Inhibitors Safe After Revascularization for Limb Disease – Medscape
MedscapeUnivadisMedscapeUnivadisNo ResultsNo ResultsMiriam E. Tucker, for MedscapeNovember 11, 2022 The study covered in this summary was published in Research Square as a preprint and has not yet been peer reviewed. Compared with…